PTPRC and melanoma: A recent study reported that miR-498 and miR-3187-3p in melanoma-derived exosomes inhibited the cytotoxic effect of CD8+ T cells by targeting IFN-α, protein tyrosine phosphatases receptor type C (PTPRC) [48].